Irulya Therapeutics Inc IRLA

$27.87 -4.53 (-13.98%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
PE ratio
—
Forward PE
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
84,300
Avg volume
28,748
Day's range
$25.13 – $30.80
Shares out
—
Stochastic %K
23%
Beta
—
Analysts
Strong Sell
Price target
—

Price

Latest news

No headlines yet.